2 completed, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 3 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Active not recruiting 1 |
| Phase 2 | 2 | Not yet recruiting 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow acetohydroxamic acid: new trials by email Literature Review of acetohydroxamic acid trials Research Report on acetohydroxamic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Acetohydroxamic Acid Combined With a Short-Course Regimen for MDR-TB (AHA-PLUS) Acetohydroxamic Acid, Placebo - Multidrug-Resistant Tuberculosis, Rifampicin-resistant Tuberculosis | Phase 2 | Not yet recruiting | Shanghai Pulmonary Hospital, Shanghai, China | 120 | 2026-02-21 | 2026-02-06 |
| Placebo-Controlled Study Assessing the Use of a Novel Exfoliative Serum With A Chemical Peel to Improve Photodamage in Adults Vitamin C with AHA Exfoliative Serum, Placebo serum - Photodamaged Skin | Not applicable | Completed | Austin Institute for Clinical Research | 34 | 2023-06-22 | 2024-07-19 |
| Manipulating the Gut Microbiome Study Acetohydroxamic Acid Oral Tablet, No treatment - Urea Cycle Disorder | Phase 1 / Phase 2 | Terminated | Nicholas Ah Mew | 4 | 2017-03-24 | 2021-12-15 |
| MyHeart Counts Cardiovascular Health Study Stand Prompt, Step Prompt, Cluster Prompt - Cardiovascular Health | Not applicable | Active not recruiting | Stanford University | 2000000 | 2015-03-01 | 2025-05-29 |
| Acute High-risk Abdominal Surgery Study - an Optimized Perioperative Course AHA (Acute Highrisk Abdominalsurgery): Optimized Course - Perforated Viscus, Intestinal Obstruction | Not applicable | Completed | Hvidovre University Hospital | 1200 | 2013-06-01 | 2015-06-12 |
Intestinal Obstruction (1) · Motor Activity (1) · Ornithine Carbamoyltransferase Deficiency Disease (1) · Tuberculosis, Multidrug-Resistant (1) · Urea Cycle Disorders, Inborn (1)
Austin Institute for Clinical Research (1) · Hvidovre University Hospital (1) · Nicholas Ah Mew (1) · Shanghai Pulmonary Hospital, Shanghai, China (1) · Stanford University (1)
United States (3) · China (1) · Denmark (1)
Edward Lain, MD, MBA (1) · Euan Ashley, MD (1) · Line T Tengberg, MD (1) · Nicholas Ah Mew, MD (1)